Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Business (Details)

v3.24.1.1.u2
Organization and Nature of Business (Details)
3 Months Ended
Sep. 28, 2023
USD ($)
$ / shares
shares
Mar. 31, 2024
USD ($)
segment
$ / shares
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
$ / shares
Jul. 14, 2023
USD ($)
$ / shares
Sep. 30, 2022
$ / shares
shares
Dec. 21, 2021
$ / shares
shares
Subsidiary, Sale of Stock [Line Items]              
Number of operating segments | segment   1          
Warrants to purchase shares | shares           500,000 172,500
Warrants exercise price | $ / shares           $ 0.625 $ 12.50
Net loss   $ 1,291,335 $ 1,516,864        
Net cash used in operating activities   937,414 $ 1,698,450        
Accumulated deficit   $ 62,760,557   $ 61,469,222      
Common stock, par value (in dollars per share) | $ / shares   $ 0.0001   $ 0.0001      
Substantial Doubt about Going Concern, within One Year [true false]   true          
Capital on Demand Sales Agreement [Member]              
Subsidiary, Sale of Stock [Line Items]              
Shares issued | shares 641,873            
Share price | $ / shares $ 2.11            
Net proceeds $ 1,156,440            
Offering costs 198,650            
Common stock, par value (in dollars per share) | $ / shares         $ 0.0001    
Aggregate offering price         $ 6,700,000    
Proceeds from issuance of shares on ATM, net of fees $ 1,355,090